Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

4-Hydroxytryptamine

From Wikipedia, the free encyclopedia
(Redirected from4-HO-T)
Serotonin receptor agonist

Pharmaceutical compound
4-Hydroxytryptamine
Clinical data
Other names4-HT; 4-HTA;N,N-Didesmethylpsilocin; Dinorpsilocin
Drug classSerotonin receptor agonist; Non-hallucinogenicserotonin5-HT2A receptoragonist
Identifiers
  • 3-(2-aminoethyl)-1H-indol-4-ol
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC10H12N2O
Molar mass176.219 g·mol−1
3D model (JSmol)
  • C1=CC2=C(C(=C1)O)C(=CN2)CCN
  • InChI=1S/C10H12N2O/c11-5-4-7-6-12-8-2-1-3-9(13)10(7)8/h1-3,6,12-13H,4-5,11H2
  • Key:FKIRTWDHOWAQGX-UHFFFAOYSA-N

4-Hydroxytryptamine (4-HT,4-HTA), also known asN,N-didesmethylpsilocin, is anaturally occurringtryptaminealkaloid.[1][2][3][4] It is closely relatedchemically to theneurotransmitterserotonin, thepsychedelicpsilocin, and is theactive form of the tryptamine alkaloidnorbaeocystin.[5][6][4]

The compound is aserotonin receptor agonist, including of the serotonin5-HT2A receptor, but in contrast to certain closely related compounds like psilocin, appears to be non-hallucinogenic.[4][7]

4-HT may occur naturally inPsilocybe baeocystis andPsilocybe cyanescens.[1][8] It may serve as an alternativeprecursor in thebiosynthesis ofpsilocybin (4-PO-DMT) inpsilocybin mushrooms.[2][9][3]

Pharmacology

[edit]

4-HT is apotentagonist of the serotonin5-HT2A receptor similarly to psilocin (EC50Tooltip half-maximal effective concentration = 38 nM and 21 nM, respectively).[4][10][11] It also shows highaffinity for the serotonin5-HT1A receptor.[10][11] The drug producesserotonergicperipheral effects in animals,[1][12] shows similarmetabolism andmetabolic stability to psilocin,[4] and appears to cross theblood–brain barrier and hence iscentrally penetrant.[4]

Surprisingly however, the compound, similarly tobaeocystin,norbaeocystin, andnorpsilocin, does not produce thehead-twitch response, a behavioral proxy of psychedelic effects, in animals, and hence is putatively non-hallucinogenic.[4][7] In older literature, thepsychoactive effects of 4-hydroxylated tryptamines have been said to increase in the series of 4-hydroxytryptamine,4-hydroxy-N-methyltryptamine (norpsilocin], and 4-hydroxy-N,N-dimethyltryptamine (psilocin).[3]

The reason for the lack of hallucinogenic effects with 4-HT and related compounds is unknown, but may be due tobiased agonism of the serotonin 5-HT2A receptor; or, more specifically, biased agonism for theβ-arrestin2 signaling pathway.[4]

Norbaeocystin is thought to be aprodrug of 4-HT, analogously to how psilocybin is a prodrug of psilocin and how baeocystin is thought to be a prodrug of norpsilocin.[6][4]

Chemistry

[edit]

4-HT, also known as 4-hydroxytryptamine, is asubstituted tryptaminederivative.[5] It is apositional isomer of theneurotransmitterserotonin (5-hydroxytryptamine; 5-HT), ananalogue of theserotonergic psychedelicpsilocin (4-HO-DMT), and thedephosphorylated form of the tryptamine alkaloidnorbaeocystin (4-phosphoryloxytryptamine; 4-PO-T).[5]

The predictedlog P of 4-HT is 0.65 to 1.1.[5][13]

Derivatives

[edit]

A large number of 4-hydroxytryptaminederivatives are known.[14][15][16][17][18][19] These includepsilocin (4-HO-DMT),norpsilocin (4-HO-NMT),4-HO-DALT,4-HO-DBT,4-HO-DET,4-HO-DiPT,4-HO-DPT,4-HO-MET,4-HO-MiPT,4-HO-MPT,4-HO-NiPT,4-HO-pyr-T, and4-HO-TMT, among others.[14][15][16][17] In addition, 4-methoxy derivatives such as4-MeO-DiPT,4-MeO-DMT, and4-MeO-MiPT; 4-acetoxy derivative such as4-AcO-DMT (psilacetin),4-AcO-DET,4-AcO-DALT,4-AcO-DiPT,4-PrO-DiPT, and4-PrO-DMT; and 4-phosphoryloxy derivatives such aspsilocybin (4-PO-DMT),baeocystin (4-PO-NMT),norbaeocystin (4-PO-T), andaeruginascin (4-PO-TMT) are known.[14][15][16][17][18][19] Many or all of these compounds areserotonin receptor agonists and/orserotonergic psychedelics.[14][15][16][17]

History

[edit]

4-HT was first described in thescientific literature by 1959.[1][20][21] Itspharmacology was first thoroughly characterized in 2024.[4]

References

[edit]
  1. ^abcdKeeper of the Trout and Friends (2007)."4-Hydroxytryptamine".Some Simple Tryptamines (2 ed.). Austin, Texas: Mydriatric Productions. p. 54.ISBN 978-0977087655.OCLC 948674100.
  2. ^abWieczorek PP, Witkowska D, Jasicka-Misiak I, Poliwoda A, Oterman M, Zielińska K (2015). "Bioactive Alkaloids of Hallucinogenic Mushrooms".Studies in Natural Products Chemistry. Vol. 46. Elsevier. pp. 133–168.doi:10.1016/b978-0-444-63462-7.00005-1.ISBN 978-0-444-63462-7.ISSN 1572-5995.
  3. ^abcWurst M, Kysilka R, Flieger M (2002). "Psychoactive tryptamines from basidiomycetes".Folia Microbiologica.47 (1):3–27.doi:10.1007/BF02818560.PMID 11980266.
  4. ^abcdefghijRakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, et al. (October 2024)."Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms".British Journal of Pharmacology.181 (19):3627–3641.doi:10.1111/bph.16466.PMID 38825326.Norpsilocin, 4-hydroxytryptamine and 4-hydroxy-N,N,Ntrimethyltryptamine have similar stability, metabolism and blood brain barrier penetration to psilocin. [...] As norpsilocin and 4-HT (active forms of baeocystin and norbaeocystin, respectively) are evidenced to be capable of crossing the BBB and bind with 5-HT2A receptors, it was surprising that neither induced significant head twitch responses at any concentration tested. However, these results concur with previous studies demonstrating these compounds do not significantly induce head twitch responses in rodents (Glatfelter et al., 2022; Sherwood et al., 2020).
  5. ^abcd"4-Hydroxytryptamine".PubChem. Retrieved5 December 2024.
  6. ^abLowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, et al. (May 2021)."The Therapeutic Potential of Psilocybin".Molecules.26 (10): 2948.doi:10.3390/molecules26102948.PMC 8156539.PMID 34063505.
  7. ^abSherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, et al. (February 2020). "Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin".Journal of Natural Products.83 (2):461–467.Bibcode:2020JNAtP..83..461S.doi:10.1021/acs.jnatprod.9b01061.PMID 32077284.
  8. ^Repke DB, Leslie DT, Guzmán G (1977). "Baeocystin in psilocybe, conocybe and panaeolus".Lloydia.40 (6):566–578.PMID 600026.
  9. ^Irvine W, Tyler M, Delgoda R (June 2023). "In silico characterization of the psilocybin biosynthesis pathway".Computational Biology and Chemistry.104: 107854.doi:10.1016/j.compbiolchem.2023.107854.PMID 36990027.
  10. ^abChen X, Li J, Yu L, Maule F, Chang L, Gallant JA, et al. (October 2023)."A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines".J Biol Chem.299 (10): 105231.doi:10.1016/j.jbc.2023.105231.PMC 10570959.PMID 37690691.
  11. ^abChen X, Li J, Yu L, Dhananjaya D, Maule F, Cook S, et al. (10 March 2023),Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery(PDF),doi:10.21203/rs.3.rs-2667175/v1, retrieved18 March 2025
  12. ^Cerletti A, Taeschler M, Weidmann H (1968).Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines. Advances in Pharmacology. Vol. 6. pp. 233–246.doi:10.1016/s1054-3589(08)60322-1.ISBN 978-0-12-032906-9.PMID 5658327.
  13. ^"4-HYDROXYTRYPTAMINE".ChemSpider. 10 June 2024. Retrieved5 December 2024.
  14. ^abcdAraújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M (August 2015). "The hallucinogenic world of tryptamines: an updated review".Arch Toxicol.89 (8):1151–1173.Bibcode:2015ArTox..89.1151A.doi:10.1007/s00204-015-1513-x.PMID 25877327.
  15. ^abcdCatalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, et al. (August 2021)."Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise".Eur Neuropsychopharmacol.49:69–92.doi:10.1016/j.euroneuro.2021.03.006.PMID 33857740.
  16. ^abcdMalaca S, Lo Faro AF, Tamborra A, Pichini S, Busardò FP, Huestis MA (December 2020)."Toxicology and Analysis of Psychoactive Tryptamines".Int J Mol Sci.21 (23): 9279.doi:10.3390/ijms21239279.PMC 7730282.PMID 33291798.S2CID 228080489.
  17. ^abcdShulgin A,Shulgin A (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  18. ^abGlatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, et al. (April 2023)."Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice".ACS Pharmacol Transl Sci.6 (4):567–577.doi:10.1021/acsptsci.2c00222.PMC 10111620.PMID 37082754.
  19. ^abKozell LB, Eshleman AJ, Swanson TL, Bloom SH, Wolfrum KM, Schmachtenberg JL, et al. (April 2023)."Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter".J Pharmacol Exp Ther.385 (1):62–75.doi:10.1124/jpet.122.001454.PMC 10029822.PMID 36669875.
  20. ^Vane JR (March 1959)."The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation".British Journal of Pharmacology and Chemotherapy.14 (1):87–98.doi:10.1111/j.1476-5381.1959.tb00933.x.PMC 1481817.PMID 13651584.
  21. ^Erspamer V, Glasser A, Mantegazzini P (November 1960). "Pharmacological actions of 4-hydroxytryptamine and 4-hydroxytryptophan".Experientia.16 (11):505–506.doi:10.1007/BF02158367.PMID 13697285.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Triptans
Cyclized tryptamines
Isotryptamines
Related compounds
Stimulants
Depressants
Hallucinogens
Entactogens
Psychiatric drugs
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=4-Hydroxytryptamine&oldid=1283268140"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp